Literature DB >> 9067544

Distribution of p53 and K-ras mutations in human lung cancer tissues.

H G Gao1, J K Chen, J Stewart, B Song, C Rayappa, W Z Whong, T Ong.   

Abstract

Studies were performed to examine the mutational pattern of K-ras exons 1 and 2 and p53 exons 5-8 in lung cancer tissues from 27 Chinese patients (10 smokers, 17 non-smokers) using single-stranded conformational polymorphism and DNA sequencing. K-ras mutations were found in 13/27 tumors (48%); all mutations were clustered in exon 1 and distributed between codons 9 and 32. The frequency and number of patients with K-ras mutations between smokers and non-smokers were not different, except that a high frequency of G --> A transitions (11/11) was found in non-smokers. Among cell types, K-ras mutations were found in 7/13 (54%) squamous cell carcinoma (SC) and 5/12 (42%) adenocarcinoma (AC) patients. A --> T transversions (all six transversions) were present only in SC. In p53, 18/27 (67%) tumors contained mutations in exons 7 and 8, frequently at codons 226, 270, 275 and 281. The number of tumors with p53 mutations in smokers (70%) and in non-smokers (65%) was similar, and the mutation frequency did not differ except for a higher number of G --> A (6/7) and T --> C (5/6) transitions in non-smokers. Among cell types, the number of tumors with p53 mutations was 9/13 (69%) in SC and 8/12 (67%) in AC. The A --> G (11/16) transitions and A --> C (4/4) transversions in p53 were more frequent in SC than in AC (P < 0.04 for A --> G; P < 0.02 for A --> C). The varying mutation patterns in both the K-ras and p53 genes between smokers and non-smokers and among cell types suggest that other than cigarette smoke, environmental and dietary factors may also be involved in the genesis of lung cancer among these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067544     DOI: 10.1093/carcin/18.3.473

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

1.  Beta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinoma.

Authors:  Hildegard M Schuller; Hussein A N Al-Wadei
Journal:  Curr Cancer Ther Rev       Date:  2012-05-01

2.  Kras, Egfr, and Tp53 Mutations in B6C3F1/N Mouse and F344/NTac Rat Alveolar/Bronchiolar Carcinomas Resulting from Chronic Inhalation Exposure to Cobalt Metal.

Authors:  Hue-Hua L Hong; Mark J Hoenerhoff; Thai-Vu Ton; Ronald A Herbert; Grace E Kissling; Michelle J Hooth; Mamta Behl; Kristine L Witt; Stephanie L Smith-Roe; Robert C Sills; Arun R Pandiri
Journal:  Toxicol Pathol       Date:  2015-06-09       Impact factor: 1.902

3.  Tobacco smoke: chemical carcinogenesis and genetic lesions.

Authors:  J L Cook
Journal:  Ochsner J       Date:  1999-07

4.  Human lung cancer and p53: the interplay between mutagenesis and selection.

Authors:  S N Rodin; A S Rodin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

5.  Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis.

Authors:  Eun-Woo Lee; Min-Sik Lee; Suzanne Camus; Jaewang Ghim; Mi-Ran Yang; Wonkyung Oh; Nam-Chul Ha; David P Lane; Jaewhan Song
Journal:  EMBO J       Date:  2009-06-18       Impact factor: 11.598

Review 6.  Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns.

Authors:  I A Lea; M A Jackson; X Li; S Bailey; S D Peddada; J K Dunnick
Journal:  Carcinogenesis       Date:  2007-08-11       Impact factor: 4.944

7.  Decreased GTPase activity of K-ras mutants deriving from human functional adrenocortical tumours.

Authors:  S R Lin; C H Hsu; J H Tsai; J Y Wang; T J Hsieh; C H Wu
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

8.  IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity.

Authors:  Daniela S Bassères; Aaron Ebbs; Patricia C Cogswell; Albert S Baldwin
Journal:  Genes Cancer       Date:  2014-04

9.  Oxidation of p53 through DNA charge transport involves a network of disulfides within the DNA-binding domain.

Authors:  Kathryn N Schaefer; Wendy M Geil; Michael J Sweredoski; Annie Moradian; Sonja Hess; Jacqueline K Barton
Journal:  Biochemistry       Date:  2015-01-13       Impact factor: 3.162

10.  A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database.

Authors:  T M Hernandez-Boussard; P Hainaut
Journal:  Environ Health Perspect       Date:  1998-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.